BI Inks Second Obesity Pact With Denmark’s Gubra

 
• By Kevin Grogan

The German group has signed a second deal with Gubra to develop poly-agonist peptides for obesity that could be worth up to €240m.

Scales
Tackling obesity is a key area for BI • Source: Shutterstock

More from Alimentary/Metabolic

More from Therapy Areas